Unified Protocol for Addressing Depression and Anxiety in Multiple Sclerosis Patients
In a pilot trial involving 30 participants with MS, those receiving the Unified Protocol (UP) for depression and anxiety showed significant reductions in depression, experiential avoidance, and fatigue. Improvements in self-efficacy, coping, quality of life, and psychological well-being were also noted, with effects maintained at a 3-month follow-up.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Not graded
- Outcome
- Not reported
Why it matters
These findings suggest that the UP may be effective in improving mental health and overall well-being in people with MS and co-occurring depression or anxiety. This is significant as mental health is crucial for the quality of life in chronic illness.
What this does not prove
The study was a pilot trial with a limited sample size, which may affect the generalizability of the results and the robustness of the findings. Moreover, it did not confirm long-term efficacy or provide insights into the mechanics behind the observed improvements.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- Not reported
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-03-23
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- people with MS and depression and/or anxiety
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceTwo Sides of the Same Coin: A Randomized Clinical Trial of the Unified Protocol for Addressing Depression and Anxiety in People With Multiple Sclerosis. ↗DOI: 10.7224/1537-2073.2025-008
Supporting passages (9)
publication datePublication date: 2026-03-23
interventionTitle: Two Sides of the Same Coin: A Randomized Clinical Trial of the Unified Protocol for Addressing Depression and Anxiety in People With Multiple Sclerosis.
comparatorMETHODS: Thirty people with MS and depression and/or anxiety were randomly assigned to a UP intervention (n = 12) or a control group (n = 18).
follow upAll completed baseline, posttreatment, and 3-month follow-up assessments.
populationMETHODS: Thirty people with MS and depression and/or anxiety were randomly assigned to a UP intervention (n = 12) or a control group (n = 18).
findingsRESULTS: Following the intervention, significant reductions in depression, experiential avoidance, and fatigue were observed. Participants also demonstrated improvements in self-efficacy, coping (eg, benefit finding, social support), QOL (eg, flourishing), and PWB (eg, acceptance). These effects were maintained at the 3-month follow-up.
limitationsTitle: Two Sides of the Same Coin: A Randomized Clinical Trial of the Unified Protocol for Addressing Depression and Anxiety in People With Multiple Sclerosis.
peer reviewedPublication types: Journal Article
subjectsTitle: Two Sides of the Same Coin: A Randomized Clinical Trial of the Unified Protocol for Addressing Depression and Anxiety in People With Multiple Sclerosis.
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.